| Protein Name | NLRC4 / IPAF |
|---|---|
| Gene | [NLRC4](/genes/nlrc4) |
| UniProt ID | [Q9NPP6](https://www.uniprot.org/uniprot/Q9NPP6) |
| PDB Structure | 5NPY, 5NPT, 6B5B |
| Molecular Weight | 1623 aa (~186 kDa) |
| Subcellular Localization | Cytoplasm |
| Protein Family | NLR family, NOD-like receptor family |
| Aliases | IPAF, CARD12, CLR17.1 |
Nlrc4 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
NLRC4 (NLR Family CARD Domain Containing 4), also known as IPAF (ICE protease-activating factor), is a member of the NOD-like receptor (NLR) family that plays a critical role in innate immunity and inflammasome assembly[^1]. Unlike other NLR proteins, NLRC4 directly recognizes bacterial components and forms a distinctive wheel-like inflammasome structure. Recent research has revealed that NLRC4 activation contributes to chronic neuroinflammation in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS)[^2]. Understanding NLRC4's role in neuroinflammation offers potential therapeutic strategies for these conditions.
NLRC4 possesses a multi-domain structure essential for its function:
Nucleotide-binding Domain (NBD/NOD) (residues 200-450): The central ATPase domain that undergoes conformational changes upon activation. This domain contains the Walker A (P-loop) and Walker B motifs characteristic of NBDs[^3]
Leucine-Rich Repeats (LRR) (residues 1200-1623): The C-terminal LRR domain is involved in ligand sensing and auto-inhibition. In the inactive state, the LRR folds back onto the NBD to maintain inactivity
Caspase Recruitment Domain (CARD) (residues 1-90): Located at the N-terminus, this domain mediates interactions with downstream effector proteins, particularly procaspase-1
FIIND Domain (Function to Find): Located between the NBD and LRR, this domain is critical for NLRC4 activation and oligomerization
Oligomerization and Wheel Formation:
Activation Mechanisms:
NLRC4 is a key component of the inflammasome, a multi-protein complex that activates inflammatory responses:
Cytokine Activation:
Pyroptosis:
Host Defense:
NLRC4 is primarily expressed in:
NLRC4 inflammasome activation contributes to AD pathogenesis[^6]:
Neuroinflammation:
Interaction with Aβ Pathology:
Therapeutic Implications:
NLRC4 plays a role in PD through microglial activation[^7]:
Dopaminergic Neuron Loss:
α-Synuclein Connection:
Therapeutic Potential:
NLRC4 is implicated in ALS pathogenesis:
Motor Neuron Inflammation:
Synergy with Other Inflammasomes:
Therapeutic Strategies:
Aβ / α-Synuclein / Mutant Protein → Microglial Activation
↓
NLRC4 Inflammasome Assembly
↓
Caspase-1 Activation
↓
IL-1β / IL-18 Release
↓
Chronic Neuroinflammation
↓
Neuronal Dysfunction and Death
Several approaches are being explored:
| Challenge | Current Approach |
|---|---|
| CNS Penetration | Develop brain-penetrant compounds |
| Specificity | Target NLRC4 specifically over NLRP3 |
| Safety | Balance inflammation control with host defense |
The identification of NLRC4 as a flagellin receptor by Lightfield et al. (2008) established its role in bacterial defense[^8]. Subsequent structural studies revealed the wheel-like architecture unique to NLRC4 inflammasomes.
Research by Walsh et al. (2014) demonstrated NLRC4 activation in Alzheimer's disease brain, establishing a direct link between this inflammasome and neurodegeneration[^9].
Preclinical studies using NLRC4 inhibitors have shown promise in reducing neuroinflammation and protecting neurons in disease models[^10].
Nlrc4 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Nlrc4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.